Global Pigmentation Disorders Treatment Market Poised for Growth, Expected to Reach $8.33 Billion by 2028

July 09, 2024 09:09 PM AEST | By EIN Presswire
 Global Pigmentation Disorders Treatment Market Poised for Growth, Expected to Reach $8.33 Billion by 2028
Image source: EIN Presswire

LONDON, GREATER LONDON, UK, July 9, 2024 /EINPresswire.com/ -- The global pigmentation disorders treatment market is projected to grow from $5.63 billion in 2023 to $6.14 billion in 2024, at a CAGR of 8.9%. The market is anticipated to reach $8.33 billion by 2028, driven by advancements in dermatological treatments, increased consumer awareness, and rising disposable incomes.

Rising Disposable Incomes Drive Market Growth
The rising disposable incomes across the world are significantly contributing to the growth of the pigmentation disorders treatment market. The growing disposable income of individuals, especially in developing regions, allows for increased spending on cosmetic and dermatological treatments. For instance, according to the October 2023 data published by the Bureau of Economic Analysis (BEA), the disposable income of Americans increased from $18,247.8 billion in the first quarter of 2022 to $19,880.2 billion in the first quarter of 2023. Therefore, the rising disposable incomes across the world will drive the pigmentation disorders treatment market.

Explore comprehensive insights into the global pigmentation disorders treatment market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=11949&type=smp

Major Players and Market Trends
Major companies operating in the pigmentation disorders treatment market include AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb, L’Oréal S.A., Astellas Pharma Inc., Bausch Health Companies Inc., Bayer AG, Strides Pharma Science Limited, Galderma S.A., Incyte Corporation, Panacea Biotec Ltd., Dr. Reddy's Laboratories Ltd., Laboratories Pierre Fabre, Glenmark Pharmaceuticals Limited., Dermavant Sciences Inc., Lumenis Be Ltd., Accord Healthcare, Obagi Medical Products Inc., Fotona d.o.o., Sesderma SL, DermaMed Solutions LLC., Vital Esthetique, Vivier Pharma, Arcutis Biotherapeutics, Episciences Inc., Phio Pharmaceuticals Inc., Scientis SA, and Philadelphia Pharmaceutical.

Trends: Nutricosmetics and Beyond
Major companies in the pigmentation disorders treatment market are focusing on developing nutricosmetics products. The integration of nutricosmetics, which involves the use of oral supplements to improve skin health, is gaining traction. Nutrients like antioxidants and vitamins are promoted for their potential to benefit pigmentation and overall skin condition. For instance, in March 2023, Symrise AG, a Germany-based chemicals company, launched Diana food bioactives for use in Beauty from within products. This collection includes solutions for skin conditioning, anti-aging, skin brightening, and hair and nail care, made up of bioactives derived from nature, such as collagen type I, vitamins C and A, and polyphenols from various fruits.

Segments:
• By Treatment Type: Topical Treatment, Dermabrasion, Chemical Peels, Laser Treatment, Phototherapy, Other Treatment Types
• By Drugs: Calcineurin Inhibitors, Melanocyte-Stimulating Hormone, Other Drug Types
• By Type Of Disorder: Albinism, Vitiligo, Melasma, Post-Inflammatory Hyperpigmentation (PIH), Other Types Of Disorder
• By Route Of Administration: Oral, Topical, Other Routes Of Administration
• By Distribution Channel: Dermatology Clinics, Aesthetic Clinics, Drugstores And Cosmetic Stores, E-Commerce, Other Distribution Channels

Geographical Insights: North America Leading, Asia-Pacific Fastest Growing
North America was the largest region in the pigmentation disorders treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pigmentation disorders treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/pigmentation-disorders-treatment-global-market-report

Pigmentation Disorders Treatment Global Market Report 2024 from TBRC covers the following information:
•Market size data for the forecast period: Historical and Future
•Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Pigmentation Disorders Treatment Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on pigmentation disorders treatment market size, pigmentation disorders treatment market drivers and trends, pigmentation disorders treatment market major players, competitors' revenues, market positioning, and market growth across geographies. The pigmentation disorders treatment market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
HPV Associated Disorders Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/hpv-associated-disorders-global-market-report

Bleeding Disorders Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

Anemia And Other Blood Disorder Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.